ANGLE’s (AGL) Buy Rating Reiterated at Berenberg Bank

Berenberg Bank reissued their buy rating on shares of ANGLE (LON:AGL) in a research report sent to investors on Wednesday morning, MarketBeat reports. Berenberg Bank currently has a GBX 70 ($0.86) price objective on the stock.

ANGLE Stock Up 3.6 %

Shares of LON AGL opened at GBX 14.50 ($0.18) on Wednesday. The company’s 50-day simple moving average is GBX 14.32 and its 200-day simple moving average is GBX 14.05. ANGLE has a 52-week low of GBX 9.07 ($0.11) and a 52-week high of GBX 37.40 ($0.46). The firm has a market cap of £37.78 million, a price-to-earnings ratio of -161.11 and a beta of 0.20. The company has a quick ratio of 6.18, a current ratio of 7.51 and a debt-to-equity ratio of 14.26.

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.